Lactobacillus rhamnosus gg/omega-3 polyunsaturated fatty acids Interactions
There are 421 drugs known to interact with lactobacillus rhamnosus gg/omega-3 polyunsaturated fatty acids, along with 3 disease interactions. Of the total drug interactions, 421 are moderate.
- View all 421 medications that may interact with lactobacillus rhamnosus gg/omega-3 polyunsaturated fatty acids
- View lactobacillus rhamnosus gg/omega-3 polyunsaturated fatty acids disease interactions (3)
Most frequently checked interactions
View interaction reports for lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Adalat (nifedipine)
- Afrin (oxymetazoline nasal)
- AllerLife Energize Daily Wellness Support (multivitamin with minerals)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Benicar (olmesartan)
- CoQ10 (ubiquinone)
- Dexilant (dexlansoprazole)
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Fluor-Op (fluorometholone ophthalmic)
- Ipratropium Inhalation Solution (ipratropium)
- L-Carnitine (levocarnitine)
- Lantus (insulin glargine)
- Lidopril XR (lidocaine / prilocaine topical)
- Lipitor (atorvastatin)
- Melatonin Time Release (melatonin)
- MiraLAX (polyethylene glycol 3350)
- NP Thyroid (thyroid desiccated)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Omega-3 Fish Oil (omega-3 polyunsaturated fatty acids)
- Ozempic (semaglutide)
- Rolaids Extra Strength (calcium carbonate / magnesium hydroxide)
- Symbicort (budesonide / formoterol)
- Tessalon (benzonatate)
- Topamax (topiramate)
- Tramadol Hydrochloride ER (tramadol)
- Trokendi XR (topiramate)
- Trulicity (dulaglutide)
- Vitamin B12 (cyanocobalamin)
Lactobacillus rhamnosus gg/omega-3 polyunsaturated fatty acids disease interactions
There are 3 disease interactions with lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.